Induction of apoptosis and inhibition of telomerase activity by arsenic trioxide (As2O3) in endometrial carcinoma cells

Chunhua Zhou(University of North Carolina at Chapel Hill), P GEHRIG(University of North Carolina at Chapel Hill), Victoria Bae‐Jump(University of North Carolina at Chapel Hill), John F. Boggess(University of Kentucky)
Gynecologic Oncology
February 5, 2007
10.1016/j.ygyno.2006.11.027
Cited by 23

Related Papers

A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study
|The Lancet Oncology|2017|929
Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
|Journal of Clinical Oncology|2004|644
A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy
|American Journal of Obstetrics and Gynecology|2008|458
Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations
|Gynecologic Oncology|2017|409
What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman?
|Gynecologic Oncology|2008|290